Trade Summary

2 days ago, BORMANN-KENNEDY BARBARA-JEAN ANNE, serving as Dir at Xeris Biopharma Holdings, Inc. (XERS), sold 16,000 shares at $6.09 per share, for a total transaction value of $97,507.20. Following this transaction, BORMANN-KENNEDY BARBARA-JEAN ANNE now holds 126,500 shares of XERS.

This sale represents a 11.23% decrease in BORMANN-KENNEDY BARBARA-JEAN ANNE's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 6:18 PM ET, 1 day after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.